column
From bench to beside: luteolin’s therapeutic promise in neurological disorders
Zhu Wenjun, Yuan Naijun, Tang Manshi, She Kaijie, Chen Man, Huang Minyi, Feng Ruotong, Ma Qingyu, Chen Jiaxu
2026, 24(10): 1153-1162. DOI: 10.1016/S1875-5364(26)61211-3
Abstract FullText HTML PDF
Broad-spectrum anticoronaviral activity of the traditional herbal medicine Mahuangtang by targeting the multistep viral infection process: virus entry, Mpro, PLpro, RdRp and IFN induction
Yoon Jiwon, Jin Young-Hee, Kim Yeonhwa, Oh Eun Young, Park Sohyun, Min Jung Sun, Ha In Jin, Kim Sanghyun, Kim Hakjin, Lee Sang-Myeong, Kwon Sunoh
2026, 24(10): 1163-1175. DOI: 10.1016/S1875-5364(26)61212-5
Abstract FullText HTML PDF
Icariin enhances PINK1-associated mitophagy to attenuate NLRP3/GSDMD-related microglial pyroptosis and cognitive impairment in Alzheimer’s disease
Fan Longmin, Jiang Haitao, Yi Min, Peng Weijun, Zhang Zheyu
2026, 24(10): 1176-1190. DOI: 10.1016/S1875-5364(26)61213-7
Abstract FullText HTML PDF
Single-cell analysis reveals synergistic therapeutic mechanisms of Shenqi Fuzheng formula against acute myocardial infarction
Wang Menglei, Li Xiang, Gao Meng, Zhu Bingjie, Wei Tiezhu, Huang Wenhua, Fan Xiaohui, Liao Jie
2026, 24(10): 1191-1204. DOI: 10.1016/S1875-5364(26)61214-9
Abstract FullText HTML PDF
Targeting senescence-associated fibrotic signatures identifies syringin as an effective modulator of the ATR/CHK1–p53 axis in idiopathic pulmonary fibrosis
Wang Yuyang, Yin Guanghui, Niu Mixing, Wang Wei, Liao Zhenyun, Yang Lei, Wu Chunli, Cao Yu, Gao Kai, Dong Zhaoxing
2026, 24(10): 1205-1220. DOI: 10.1016/S1875-5364(26)61215-0
Abstract FullText HTML PDF
Data mining and multi-omics profiling to reveal the mechanisms of cold/hot property of traditional Chinese medicine in Alzheimer’s disease treatment
Zhu Mingtao, Wang Yu, Tang Haipeng, Sun Yanping, Feng Xiaotao, Wang Qiuhong, Kuang Haixue
2026, 24(10): 1221-1236. DOI: 10.1016/S1875-5364(26)61216-2
Abstract FullText HTML PDF
Gypensapogenin I ameliorates liver fibrosis by targeting MST1, restoring Hippo pathway homeostasis, and inhibiting HSCs activation
Huang Kexin, Chen Xiaoxu, Pei Hanbo, Yang Nan, Miao Yuxin, Zhang Xiaoshu, Yue Jiayin
2026, 24(10): 1237-1250. DOI: 10.1016/S1875-5364(26)61217-4
Abstract FullText HTML PDF
Kaurepenoid A, a 2-nor-ent-kaurane diterpenoid with P-glycoprotein-mediated reversal of multidrug resistance activity from the fungus Bipolaris sp.
Shen Yong, Ding Nanjin, Zheng Meijia, Guo Tianyuan, Gu Xiaoxia, Liang Yu, Chen Chunmei, Li Qin, Zhang Yonghui, Zhu Hucheng
2026, 24(10): 1251-1261. DOI: 10.1016/S1875-5364(26)61218-6
Abstract FullText HTML PDF
Hyperperins A–X, fusicoccane diterpenoids including an unreported 5/7/5/3 tetracyclic carbon skeleton from Hypoestes purpurea and their T-type calcium channel inhibitory activity
Ding Linfen, Hu Ming, Wei Qiaoling, Yin Shihuan, Wang Xinying, Sai Lu, Li Wenyan, Wu Xingde
2026, 24(10): 1262-1280. DOI: 10.1016/S1875-5364(26)61219-8
Abstract FullText HTML PDF